Wellington Management Group LLP Has $10.18 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Wellington Management Group LLP trimmed its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 44.4% in the 2nd quarter, HoldingsChannel reports. The firm owned 521,899 shares of the real estate investment trust’s stock after selling 416,290 shares during the quarter. Wellington Management Group LLP’s holdings in Sabra Healthcare REIT were worth $10,182,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. PNC Financial Services Group Inc. raised its holdings in Sabra Healthcare REIT by 2.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock worth $451,000 after buying an additional 528 shares during the period. Larson Financial Group LLC boosted its holdings in shares of Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. Inspire Investing LLC increased its position in shares of Sabra Healthcare REIT by 2.3% in the fourth quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after acquiring an additional 565 shares in the last quarter. Natixis Advisors LLC increased its position in shares of Sabra Healthcare REIT by 2.2% in the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after acquiring an additional 598 shares in the last quarter. Finally, Versant Capital Management Inc raised its holdings in shares of Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 603 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

NASDAQ SBRA opened at $20.81 on Wednesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The firm has a market capitalization of $5.32 billion, a price-to-earnings ratio of 80.04, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The company has a 50 day simple moving average of $20.66 and a 200-day simple moving average of $20.20. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business’s revenue for the quarter was up 24.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.38 earnings per share. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. The ex-dividend date was Friday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 461.54%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Scotiabank lowered their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Robert W. Baird increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, August 31st. Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research report on Thursday, August 6th. Finally, Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $22.17.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.